103 related articles for article (PubMed ID: 1989799)
1. Macrophage colony-stimulating factor activity in malignant pleural effusions. Its augmentation by intrapleural interleukin-2 infusions.
Sone S; Nakanishi M; Ohmoto Y; Yanagawa H; Ogura T
Chest; 1991 Feb; 99(2):377-81. PubMed ID: 1989799
[TBL] [Abstract][Full Text] [Related]
2. [Colony-stimulating factor activity in malignant pleural effusions and its augmentation by local administration of interleukin 2].
Nakanishi M; Sone S; Ogura T
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jul; 29(7):824-8. PubMed ID: 1920977
[TBL] [Abstract][Full Text] [Related]
3. IL-6 in malignant pleural effusions and its augmentation by intrapleural instillation of IL-2.
Yanagawa H; Sone S; Munekata M; Atagi S; Nii A; Ogura T
Clin Exp Immunol; 1992 May; 88(2):207-12. PubMed ID: 1315227
[TBL] [Abstract][Full Text] [Related]
4. [Induction by local injections of IL-2 of antitumor effector cells and secondary production of cytokines in malignant pleural effusion].
Sone S; Yanagawa H; Nii A; Ozaki T; Ogura T
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Aug; 30(8):1434-40. PubMed ID: 1434216
[TBL] [Abstract][Full Text] [Related]
5. Eosinophil colony-stimulating factor induced by administration of interleukin-2 into the pleural cavity of patients with malignant pleurisy.
Nakamura Y; Ozaki T; Yanagawa H; Yasuoka S; Ogura T
Am J Respir Cell Mol Biol; 1990 Oct; 3(4):291-300. PubMed ID: 2206537
[TBL] [Abstract][Full Text] [Related]
6. Production of granulocyte-macrophage colony-stimulating factor in two patients with lung cancer, leukocytosis, and eosinophilia.
Sawyers CL; Golde DW; Quan S; Nimer SD
Cancer; 1992 Mar; 69(6):1342-6. PubMed ID: 1540871
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte-macrophage colony-stimulating factor augments lymphokine-activated killer activity from pleural cavity mononuclear cells of lung cancer patients without malignant effusion.
Takahashi K; Sone S; Saito S; Kamamura Y; Uyama T; Ogura T; Monden Y
Jpn J Cancer Res; 1995 Sep; 86(9):861-6. PubMed ID: 7591964
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness of treatment with transfer of autologous or allogenic LAK cells combined with rIL-2 in 121 patients with malignant pleural effusion].
Liu X
Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):205-8. PubMed ID: 8261867
[TBL] [Abstract][Full Text] [Related]
9. [Intrapleural administration of LAK cells combined with rIL2 in the treatment of advanced lung cancer with malignant pleural effusion].
Mao G; Gao Z; Wang Q
Zhonghua Jie He He Hu Xi Za Zhi; 1995 Apr; 18(2):83-4, 127. PubMed ID: 7553956
[TBL] [Abstract][Full Text] [Related]
10. Intrapleural application of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer. A multi-institutional cooperative study.
Yasumoto K; Ogura T
Biotherapy; 1991; 3(4):345-9. PubMed ID: 1786198
[TBL] [Abstract][Full Text] [Related]
11. Induction of lymphokine-activated killer cells by intrapleural instillations of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer.
Yasumoto K; Mivazaki K; Nagashima A; Ishida T; Kuda T; Yano T; Sugimachi K; Nomoto K
Cancer Res; 1987 Apr; 47(8):2184-7. PubMed ID: 3493843
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of malignant effusions with the injection of dendritic cells derived from autologous peripheral CD34+ stem cells].
Di LJ; Ren J; Song GH; Yu J; Fang J; Che L; Zhu YL
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):486-8. PubMed ID: 18931710
[TBL] [Abstract][Full Text] [Related]
13. Leukaemia inhibitory factor (LIF) production in pleural effusions: comparison with production of IL-4, IL-8, IL-10 and macrophage-colony stimulating factor (M-CSF).
Heymann D; L'Her E; NGuyen JM; Raher S; Canfrère I; Coupey L; Fixe P; Chailleux E; De Groote D; Praloran V; Godard A
Cytokine; 1996 May; 8(5):410-6. PubMed ID: 8726670
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor in malignant pleural effusion associated with lung cancer.
Yanagawa H; Takeuchi E; Suzuki Y; Ohmoto Y; Bando H; Sone S
Cancer Immunol Immunother; 1999 Oct; 48(7):396-400. PubMed ID: 10501853
[TBL] [Abstract][Full Text] [Related]
15. [Eosinophil colony stimulating activity induced by administration of interleukin-2 into the pleural cavity of patients with malignant pleurisy].
Nakamura Y; Ozaki T; Kamei T; Kawaji K; Fujisawa K; Nii A; Yanagawa H; Nishioka Y; Shimizu E; Sone S
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Oct; 28(10):1314-20. PubMed ID: 2273659
[TBL] [Abstract][Full Text] [Related]
16. Antitumor protection from the murine T-cell leukemia/lymphoma EL4 by the continuous subcutaneous coadministration of recombinant macrophage-colony stimulating factor and interleukin-2.
Vallera DA; Taylor PA; Aukerman SL; Blazar BR
Cancer Res; 1993 Sep; 53(18):4273-80. PubMed ID: 8364923
[TBL] [Abstract][Full Text] [Related]
17. Detection of endogenous macrophage colony-stimulating factor (M-CSF) in human blood.
Shadle PJ; Allen JI; Geier MD; Koths K
Exp Hematol; 1989 Feb; 17(2):154-9. PubMed ID: 2643519
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy in patients with malignant pleural effusions from non-small cell lung cancer : cisplatin, ifosfamide, and irinotecan with recombinant human granulocyte colony-stimulating factor support.
Fujita A; Takabatake H; Tagaki S; Sekine K
Chest; 2001 Feb; 119(2):340-3. PubMed ID: 11171707
[TBL] [Abstract][Full Text] [Related]
19. Factors that stimulate the proliferation and survival of eosinophils in eosinophilic pleural effusion: relationship to granulocyte/macrophage colony-stimulating factor, interleukin-5, and interleukin-3.
Nakamura Y; Ozaki T; Kamei T; Kawaji K; Banno K; Miki S; Fujisawa K; Yasuoka S; Ogura T
Am J Respir Cell Mol Biol; 1993 Jun; 8(6):605-11. PubMed ID: 8323745
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions.
Zebrowski BK; Yano S; Liu W; Shaheen RM; Hicklin DJ; Putnam JB; Ellis LM
Clin Cancer Res; 1999 Nov; 5(11):3364-8. PubMed ID: 10589746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
